These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25599530)

  • 1. The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease. An emerging field.
    Polyzos KA; Ketelhuth DF
    Hamostaseologie; 2015; 35(2):128-36. PubMed ID: 25599530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice.
    Polyzos KA; Ovchinnikova O; Berg M; Baumgartner R; Agardh H; Pirault J; Gisterå A; Assinger A; Laguna-Fernandez A; Bäck M; Hansson GK; Ketelhuth DF
    Cardiovasc Res; 2015 May; 106(2):295-302. PubMed ID: 25750192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunometabolic role of indoleamine 2,3-dioxygenase in atherosclerotic cardiovascular disease: immune homeostatic mechanisms in the artery wall.
    Ketelhuth DFJ
    Cardiovasc Res; 2019 Jul; 115(9):1408-1415. PubMed ID: 30847484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.
    Song P; Ramprasath T; Wang H; Zou MH
    Cell Mol Life Sci; 2017 Aug; 74(16):2899-2916. PubMed ID: 28314892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between Tryptophan Metabolism and Cardiovascular Disease, Mechanisms, and Therapeutic Implications.
    Liu G; Chen S; Zhong J; Teng K; Yin Y
    Oxid Med Cell Longev; 2017; 2017():1602074. PubMed ID: 28377795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tryptophan Metabolism in Atherosclerosis and Diabetes.
    Sudar-Milovanovic E; Gluvic Z; Obradovic M; Zaric B; Isenovic ER
    Curr Med Chem; 2022; 29(1):99-113. PubMed ID: 34269660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.
    Ball HJ; Yuasa HJ; Austin CJ; Weiser S; Hunt NH
    Int J Biochem Cell Biol; 2009 Mar; 41(3):467-71. PubMed ID: 18282734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.
    Oxenkrug GF
    Ann N Y Acad Sci; 2007 Dec; 1122():35-49. PubMed ID: 18077563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interplay between cytokines and the Kynurenine pathway in inflammation and atherosclerosis.
    Baumgartner R; Forteza MJ; Ketelhuth DFJ
    Cytokine; 2019 Oct; 122():154148. PubMed ID: 28899580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
    Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ
    Neuropharmacology; 2017 Jan; 112(Pt B):373-388. PubMed ID: 26995730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolism of tryptophan via the kynurenine pathway in saliva].
    Buczko W; Cylwik D; Stokowska W
    Postepy Hig Med Dosw (Online); 2005; 59():283-9. PubMed ID: 15995595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Interactions Between Kynurenine, Folate, Methionine and Pteridine Pathways in Obesity.
    Engin AB; Engin A
    Adv Exp Med Biol; 2017; 960():511-527. PubMed ID: 28585214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism.
    Oxenkrug GF
    Ann N Y Acad Sci; 2010 Jun; 1199():1-14. PubMed ID: 20633104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes.
    Belladonna ML; Puccetti P; Orabona C; Fallarino F; Vacca C; Volpi C; Gizzi S; Pallotta MT; Fioretti MC; Grohmann U
    Transplantation; 2007 Jul; 84(1 Suppl):S17-20. PubMed ID: 17632406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease.
    Macchiarulo A; Camaioni E; Nuti R; Pellicciari R
    Amino Acids; 2009 Jul; 37(2):219-29. PubMed ID: 18612775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats.
    Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Grant R
    FEBS J; 2011 Nov; 278(22):4425-34. PubMed ID: 22032336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role for kynurenines in metabolic pathologies.
    Liu JJ; Movassat J; Portha B
    Curr Opin Clin Nutr Metab Care; 2019 Jan; 22(1):82-90. PubMed ID: 30407222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor immune escape mediated by indoleamine 2,3-dioxygenase.
    Zamanakou M; Germenis AE; Karanikas V
    Immunol Lett; 2007 Aug; 111(2):69-75. PubMed ID: 17644189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis.
    Criado G; Simelyte E; Inglis JJ; Essex D; Williams RO
    Arthritis Rheum; 2009 May; 60(5):1342-51. PubMed ID: 19404944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
    Quak J; Doornbos B; Roest AM; Duivis HE; Vogelzangs N; Nolen WA; Penninx BW; Kema IP; de Jonge P
    Psychoneuroendocrinology; 2014 Jul; 45():202-10. PubMed ID: 24845191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.